Toll Free: 1-888-928-9744

Head And Neck Cancer - Pipeline Review, H2 2015

Published: Dec 30, 2015 | Pages: 1011 | Publisher: Global Markets Direct | Industry: Pharmaceutical | Report Format: Electronic (PDF)

Head And Neck Cancer - Pipeline Review, H2 2015

Summary

Global Markets Directs, Head And Neck Cancer - Pipeline Review, H2 2015, provides an overview of the Head And Neck Cancers therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Head And Neck Cancer and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Head And Neck Cancer and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Head And Neck Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Head And Neck Cancer pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Head And Neck Cancer
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Head And Neck Cancer pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
 Table of Contents

Introduction 9
Head And Neck Cancer Overview 10
Therapeutics Development 11
Head And Neck Cancer - Therapeutics under Development by Companies 13
Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes 26
Head And Neck Cancer - Pipeline Products Glance 29
Head And Neck Cancer - Products under Development by Companies 33
Head And Neck Cancer - Products under Investigation by Universities/Institutes 51
Head And Neck Cancer - Companies Involved in Therapeutics Development 53
Head And Neck Cancer - Therapeutics Assessment 203
Drug Profiles 228
Head And Neck Cancer - Recent Pipeline Updates 711
Head And Neck Cancer - Dormant Projects 961
Head And Neck Cancer - Discontinued Products 972
Head And Neck Cancer - Product Development Milestones 975

Appendix 982
List of Tables

Number of Products under Development for Head And Neck Cancer, H2 2015 39
Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2015 40
Number of Products under Development by Companies, H2 2015 42
Number of Products under Development by Companies, H2 2015 (Contd..1) 43
Number of Products under Development by Companies, H2 2015 (Contd..2) 44
Number of Products under Development by Companies, H2 2015 (Contd..3) 45
Number of Products under Development by Companies, H2 2015 (Contd..4) 46
Number of Products under Development by Companies, H2 2015 (Contd..5) 47
Number of Products under Development by Companies, H2 2015 (Contd..6) 48
Number of Products under Development by Companies, H2 2015 (Contd..7) 49
Number of Products under Development by Companies, H2 2015 (Contd..8) 50
Number of Products under Development by Companies, H2 2015 (Contd..9) 51
Number of Products under Development by Companies, H2 2015 (Contd..10) 52
Number of Products under Development by Companies, H2 2015 (Contd..11) 53
Number of Products under Investigation by Universities/Institutes, H2 2015 55
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1) 56
Comparative Analysis by Late Stage Development, H2 2015 57
Comparative Analysis by Clinical Stage Development, H2 2015 58
Comparative Analysis by Early Stage Development, H2 2015 59
Comparative Analysis by Unknown Stage Development, H2 2015 60
Products under Development by Companies, H2 2015 61
Products under Development by Companies, H2 2015 (Contd..1) 62
Products under Development by Companies, H2 2015 (Contd..2) 63
Products under Development by Companies, H2 2015 (Contd..3) 64
Products under Development by Companies, H2 2015 (Contd..4) 65
Products under Development by Companies, H2 2015 (Contd..5) 66
Products under Development by Companies, H2 2015 (Contd..6) 67
Products under Development by Companies, H2 2015 (Contd..7) 68
Products under Development by Companies, H2 2015 (Contd..8) 69
Products under Development by Companies, H2 2015 (Contd..9) 70
Products under Development by Companies, H2 2015 (Contd..10) 71
Products under Development by Companies, H2 2015 (Contd..11) 72
Products under Development by Companies, H2 2015 (Contd..12) 73
Products under Development by Companies, H2 2015 (Contd..13) 74
Products under Development by Companies, H2 2015 (Contd..14) 75
Products under Development by Companies, H2 2015 (Contd..15) 76
Products under Development by Companies, H2 2015 (Contd..16) 77
Products under Development by Companies, H2 2015 (Contd..17) 78
Products under Investigation by Universities/Institutes, H2 2015 79
Products under Investigation by Universities/Institutes, H2 2015 (Contd..1) 80
Head And Neck Cancer - Pipeline by 4SC AG, H2 2015 81
Head And Neck Cancer - Pipeline by AB Science SA, H2 2015 82
Head And Neck Cancer - Pipeline by AbbVie Inc., H2 2015 83
Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H2 2015 84
Head And Neck Cancer - Pipeline by Advaxis, Inc., H2 2015 85
Head And Neck Cancer - Pipeline by Alchemia Limited, H2 2015 86
Head And Neck Cancer - Pipeline by Altor BioScience Corporation, H2 2015 87
Head And Neck Cancer - Pipeline by Ambrx, Inc., H2 2015 88
Head And Neck Cancer - Pipeline by Amgen Inc., H2 2015 89
Head And Neck Cancer - Pipeline by ANP Technologies, Inc., H2 2015 90
Head And Neck Cancer - Pipeline by arGEN-X BV, H2 2015 91
Head And Neck Cancer - Pipeline by ArQule, Inc., H2 2015 92
Head And Neck Cancer - Pipeline by Ascenta Therapeutics, Inc., H2 2015 93
Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H2 2015 94
Head And Neck Cancer - Pipeline by Astex Pharmaceuticals, Inc., H2 2015 95
Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2015 96
Head And Neck Cancer - Pipeline by ATLAB Pharma SAS, H2 2015 97
Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2015 98
Head And Neck Cancer - Pipeline by Bayer AG, H2 2015 99
Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC., H2 2015 100
Head And Neck Cancer - Pipeline by BIND Therapeutics, Inc., H2 2015 101
Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H2 2015 102
Head And Neck Cancer - Pipeline by BioDiem Ltd, H2 2015 103
Head And Neck Cancer - Pipeline by Bionovis SA, H2 2015 104
Head And Neck Cancer - Pipeline by Biotest AG, H2 2015 105
Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2015 106
Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H2 2015 107
Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2015 108
Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H2 2015 109
Head And Neck Cancer - Pipeline by Celgene Corporation, H2 2015 110
Head And Neck Cancer - Pipeline by Cell Medica Limited, H2 2015 111
Head And Neck Cancer - Pipeline by Cellceutix Corporation, H2 2015 112
Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2015 113
Head And Neck Cancer - Pipeline by Celltrion, Inc., H2 2015 114
Head And Neck Cancer - Pipeline by Centrose LLC, H2 2015 115
Head And Neck Cancer - Pipeline by Cristal Therapeutics, H2 2015 116
Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2015 117
Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H2 2015 118
Head And Neck Cancer - Pipeline by CytomX Therapeutics, Inc., H2 2015 119
Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2015 120
Head And Neck Cancer - Pipeline by EcoBiotics Limited, H2 2015 121
Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H2 2015 122
Head And Neck Cancer - Pipeline by Eli Lilly and Company, H2 2015 123
Head And Neck Cancer - Pipeline by EntreChem, S.L., H2 2015 124
Head And Neck Cancer - Pipeline by Etubics Corporation, H2 2015 125
Head And Neck Cancer - Pipeline by Eureka Therapeutics, Inc., H2 2015 126
Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015 127
Head And Neck Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2015 128
Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2015 129
Head And Neck Cancer - Pipeline by Genelux Corporation, H2 2015 130
Head And Neck Cancer - Pipeline by Genentech, Inc., H2 2015 131
Head And Neck Cancer - Pipeline by Genexine, Inc., H2 2015 132
Head And Neck Cancer - Pipeline by Genmab A/S, H2 2015 133
Head And Neck Cancer - Pipeline by Genticel S.A., H2 2015 134
Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2 2015 135
Head And Neck Cancer - Pipeline by Gliknik, Inc., H2 2015 136
Head And Neck Cancer - Pipeline by Glycotope GmbH, H2 2015 137
Head And Neck Cancer - Pipeline by Green Cross Corporation, H2 2015 138
Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015 139
Head And Neck Cancer - Pipeline by HEC Pharm Co., Ltd., H2 2015 140
Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2 2015 141
Head And Neck Cancer - Pipeline by Ignyta, Inc., H2 2015 142
Head And Neck Cancer - Pipeline by ImmunoGen, Inc., H2 2015 143
Head And Neck Cancer - Pipeline by Immunomedics, Inc., H2 2015 144
Head And Neck Cancer - Pipeline by Immunovaccine, Inc., H2 2015 145
Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2015 146
Head And Neck Cancer - Pipeline by Incyte Corporation, H2 2015 147
Head And Neck Cancer - Pipeline by Innate Pharma SA, H2 2015 148
Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2015 149
Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H2 2015 150
Head And Neck Cancer - Pipeline by IRX Therapeutics, Inc., H2 2015 151
Head And Neck Cancer - Pipeline by ISA Pharmaceuticals B.V., H2 2015 152
Head And Neck Cancer - Pipeline by ISU ABXIS Co.,Ltd., H2 2015 153
Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2015 154
Head And Neck Cancer - Pipeline by Johnson & Johnson, H2 2015 155
Head And Neck Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015 156
Head And Neck Cancer - Pipeline by Kite Pharma, Inc., H2 2015 157
Head And Neck Cancer - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2015 158
Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2 2015 159
Head And Neck Cancer - Pipeline by Loxo Oncology, Inc., H2 2015 160
Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2 2015 161
Head And Neck Cancer - Pipeline by Mabion SA, H2 2015 162
Head And Neck Cancer - Pipeline by Mabtech Limited, H2 2015 163
Head And Neck Cancer - Pipeline by MacroGenics, Inc., H2 2015 164
Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H2 2015 165
Head And Neck Cancer - Pipeline by Meabco A/S, H2 2015 166
Head And Neck Cancer - Pipeline by MedImmune, LLC, H2 2015 167
Head And Neck Cancer - Pipeline by Merck & Co., Inc., H2 2015 168
Head And Neck Cancer - Pipeline by Merck KGaA, H2 2015 169
Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2015 170
Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H2 2015 171
Head And Neck Cancer - Pipeline by Molplex Ltd., H2 2015 172
Head And Neck Cancer - Pipeline by Multimmune GmbH, H2 2015 173
Head And Neck Cancer - Pipeline by NanoCarrier Co., Ltd., H2 2015 174
Head And Neck Cancer - Pipeline by Natco Pharma Limited, H2 2015 175
Head And Neck Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2015 176
Head And Neck Cancer - Pipeline by Novartis AG, H2 2015 177
Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H2 2015 178
Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H2 2015 179
Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc., H2 2015 180
Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H2 2015 181
Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2015 182
Head And Neck Cancer - Pipeline by OncoSec Medical Inc., H2 2015 183
Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2015 184
Head And Neck Cancer - Pipeline by Orbis Biosciences, Inc., H2 2015 185
Head And Neck Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2015 186
Head And Neck Cancer - Pipeline by Otsuka Holdings Co., Ltd., H2 2015 187
Head And Neck Cancer - Pipeline by OXiGENE, Inc., H2 2015 188
Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H2 2015 189
Head And Neck Cancer - Pipeline by PCI Biotech AS, H2 2015 190
Head And Neck Cancer - Pipeline by Pfizer Inc., H2 2015 191
Head And Neck Cancer - Pipeline by Pharma Mar, S.A., H2 2015 192
Head And Neck Cancer - Pipeline by Pharmacyclics, Inc., H2 2015 193
Head And Neck Cancer - Pipeline by Pique Therapeutics, H2 2015 194
Head And Neck Cancer - Pipeline by Plexxikon Inc., H2 2015 195
Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H2 2015 196
Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H2 2015 197
Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2 2015 198
Head And Neck Cancer - Pipeline by Sanofi, H2 2015 199
Head And Neck Cancer - Pipeline by Sapvax, H2 2015 200
Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2 2015 201
Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H2 2015 202
Head And Neck Cancer - Pipeline by Serina Therapeutics, Inc., H2 2015 203
Head And Neck Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2015 204
Head And Neck Cancer - Pipeline by Shenzen SiBiono GeneTech Co., Ltd, H2 2015 205
Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H2 2015 206
Head And Neck Cancer - Pipeline by Silence Therapeutics Plc, H2 2015 207
Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2 2015 208
Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2015 209
Head And Neck Cancer - Pipeline by Sorrento Therapeutics, Inc., H2 2015 210
Head And Neck Cancer - Pipeline by SuviCa Inc., H2 2015 211
Head And Neck Cancer - Pipeline by Symphogen A/S, H2 2015 212
Head And Neck Cancer - Pipeline by Synta Pharmaceuticals Corp., H2 2015 213
Head And Neck Cancer - Pipeline by Taiwan Liposome Company, Ltd., H2 2015 214
Head And Neck Cancer - Pipeline by Takara Bio Inc., H2 2015 215
Head And Neck Cancer - Pipeline by Takis S.r.l., H2 2015 216
Head And Neck Cancer - Pipeline by Teva Pharmaceutical Industries Limited, H2 2015 217
Head And Neck Cancer - Pipeline by Theravectys SA, H2 2015 218
Head And Neck Cancer - Pipeline by Threshold Pharmaceuticals, Inc., H2 2015 219
Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals, Inc., H2 2015 220
Head And Neck Cancer - Pipeline by Vaccibody AS, H2 2015 221
Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H2 2015 222
Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2015 223
Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H2 2015 224
Head And Neck Cancer - Pipeline by Viventia Bio Inc., H2 2015 225
Head And Neck Cancer - Pipeline by VLPbio, H2 2015 226
Head And Neck Cancer - Pipeline by VM Discovery, Inc., H2 2015 227
Head And Neck Cancer - Pipeline by Zhejiang BetaPharma Co., Ltd., H2 2015 228
Head And Neck Cancer - Pipeline by Zymeworks Inc., H2 2015 229
Head And Neck Cancer - Pipeline by Zyngenia, Inc., H2 2015 230
Assessment by Monotherapy Products, H2 2015 231
Assessment by Combination Products, H2 2015 232
Number of Products by Stage and Target, H2 2015 234
Number of Products by Stage and Mechanism of Action, H2 2015 245
Number of Products by Stage and Route of Administration, H2 2015 253
Number of Products by Stage and Molecule Type, H2 2015 255
Head And Neck Cancer Therapeutics - Recent Pipeline Updates, H2 2015 739
Head And Neck Cancer - Dormant Projects, H2 2015 989
Head And Neck Cancer - Dormant Projects (Contd..1), H2 2015 990
Head And Neck Cancer - Dormant Projects (Contd..2), H2 2015 991
Head And Neck Cancer - Dormant Projects (Contd..3), H2 2015 992
Head And Neck Cancer - Dormant Projects (Contd..4), H2 2015 993
Head And Neck Cancer - Dormant Projects (Contd..5), H2 2015 994
Head And Neck Cancer - Dormant Projects (Contd..6), H2 2015 995
Head And Neck Cancer - Dormant Projects (Contd..7), H2 2015 996
Head And Neck Cancer - Dormant Projects (Contd..8), H2 2015 997
Head And Neck Cancer - Dormant Projects (Contd..9), H2 2015 998
Head And Neck Cancer - Dormant Projects (Contd..10), H2 2015 999
Head And Neck Cancer - Discontinued Products, H2 2015 1000
Head And Neck Cancer - Discontinued Products (Contd..1), H2 2015 1001
Head And Neck Cancer - Discontinued Products (Contd..2), H2 2015 1002 


List of Figures

Number of Products under Development for Head And Neck Cancer, H2 2015 39
Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2015 40
Number of Products under Development by Companies, H2 2015 41
Number of Products under Investigation by Universities/Institutes, H2 2015 54
Comparative Analysis by Clinical Stage Development, H2 2015 58
Comparative Analysis by Early Stage Products, H2 2015 59
Assessment by Monotherapy Products, H2 2015 231
Assessment by Combination Products, H2 2015 232
Number of Products by Top 10 Targets, H2 2015 233
Number of Products by Stage and Top 10 Targets, H2 2015 233
Number of Products by Top 10 Mechanism of Actions, H2 2015 244
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 244
Number of Products by Top 10 Routes of Administration, H2 2015 252
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 252
Number of Products by Top 10 Molecule Types, H2 2015 254
Number of Products by Stage and Top 10 Molecule Types, H2 2015 254

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify